//
Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure
Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction
Circulating sST2 and catestatin levels in patients with acute worsening of heart failure: a report from the CATSTAT-HF study
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
Effects of Dapagliflozin on Symptoms, Function and Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Results from the DAPA-HF Trial
Lifestyle Modifications for Preventing and Treating Heart Failure
AIM2-driven inflammasome activation in heart failure
H2FPEF Score for Predicting Future Heart Failure in Stable Outpatients With Cardiovascular Risk Factors